Emerging Therapies for Relapsed/Refractory Multiple Myeloma

All hematologist-oncologists, oncologists, internal medicine physicians, oncology nurses, and family medicine who care for patients with multiple myeloma can find Emerging Therapies for Relapsed/Refractory Multiple Myeloma to be extremely helpful. This course consists of a single lecture.

Get easy access now to become eligible to identify disease-related, patient-related, and cytogenetic factors that shape treatment decisions for the management of relapsed/refractory MM. Moreover, adopt evidence-based practices in managing carcinoid syndrome and find the therapeutic implications of combination regimens involving emerging agents with a currently available treatment option.